Combined Irinotecan and Oxaliplatin in Patients with Advanced Pre-Treated Pancreatic Cancer

Publisher： Karger

E-ISSN： 1423-0232|67|2|93-97

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.2, 2004-10, pp. : 93-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Irinotecan, Oxaliplatin and 5-Fluorouracil in Patients with Advanced Colorectal Cancer

By  

Oncology, Vol. 63, Iss. 3, 2002-10 ,pp. : 254-265

Karger

Access to resources Recommend Favorite

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 301-306

Karger

Access to resources Recommend Favorite

Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 221-227

Karger

Access to resources Recommend Favorite

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

Multicenter Phase II Study of Gemcitabine and Oxaliplatin (GEMOX) as Second-Line Chemotherapy in Colorectal Cancer Patients Pretreated with 5-Fluorouracil plus Irinotecan

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 106-114

Karger

Access to resources Recommend Favorite